129 related articles for article (PubMed ID: 38562007)
1. Circulating levels of carbohydrate antigen 125 in chronic heart failure: Useful or futile?
Morillas H; Núñez J; Moliner P
Eur J Heart Fail; 2024 Apr; 26(4):803-805. PubMed ID: 38562007
[No Abstract] [Full Text] [Related]
2. Factors associated with plasma antigen carbohydrate 125 and amino-terminal pro-B-type natriuretic peptide concentrations in acute heart failure.
Miñana G; de la Espriella R; Mollar A; Santas E; Núñez E; Valero E; Bodí V; Chorro FJ; Fernández-Cisnal A; Martí-Cervera J; Sanchis J; Bayés-Genís A; Núñez J
Eur Heart J Acute Cardiovasc Care; 2020 Aug; 9(5):437-447. PubMed ID: 32129669
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of antigen carbohydrate 125 in heart failure.
Núñez J; Miñana G; Núñez E; Chorro FJ; Bodí V; Sanchis J
Heart Fail Rev; 2014 Sep; 19(5):575-84. PubMed ID: 23925386
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.
Ordu S; Ozhan H; Alemdar R; Aydin M; Caglar O; Yuksel H; Kandis H
Tex Heart Inst J; 2012; 39(1):30-5. PubMed ID: 22412224
[TBL] [Abstract][Full Text] [Related]
5. Prognostic effect of carbohydrate antigen 125-guided therapy in patients recently discharged for acute heart failure (CHANCE-HF). Study design.
Núñez J; Merlos P; Fácila L; Llàcer P; Bosch MJ; Bertomeu-Martínez V; García-Blas S; Montagud V; Pedrosa V; Mendizábal A; Cordero A; Miñana G; Sanchis J; Bertomeu-González V;
Rev Esp Cardiol (Engl Ed); 2015 Feb; 68(2):121-8. PubMed ID: 25623430
[TBL] [Abstract][Full Text] [Related]
6. Carbohydrate antigen 125 in heart failure. New era in the monitoring and control of treatment.
Llàcer P; Bayés-Genís A; Núñez J
Med Clin (Barc); 2019 Apr; 152(7):266-273. PubMed ID: 30442374
[TBL] [Abstract][Full Text] [Related]
7. Using Biomarkers to Guide Heart Failure Therapy.
Jaffe AS; Januzzi JL
Clin Chem; 2017 May; 63(5):954-957. PubMed ID: 28280051
[No Abstract] [Full Text] [Related]
8. Serum carbohydrate antigen 125 has prognostic significance in heart failure, but no implications on treatment.
Beton O; Yucel O
Int J Cardiol; 2011 Sep; 151(2):241. PubMed ID: 21724271
[No Abstract] [Full Text] [Related]
9. Carbohydrate antigen 125: a useful marker of congestion, fibrosis, and prognosis in heart failure with preserved ejection fraction.
Menghoum N; Badii MC; Deltombe M; Lejeune S; Roy C; Vancraeynest D; Pasquet A; Gerber BL; Horman S; Gruson D; Beauloye C; Pouleur AC
ESC Heart Fail; 2024 Jun; 11(3):1493-1505. PubMed ID: 38339764
[TBL] [Abstract][Full Text] [Related]
10. Insights into the clinical implications of carbohydrate antigen 125 as a biomarker of heart failure: a meta-analysis and systematic review of published studies.
Zhuang J; Faggiano P; Li Q; Pradelli D; Med V; Peng W; Zuo M; Xu Y
J Cardiovasc Med (Hagerstown); 2014 Dec; 15(12):864-72. PubMed ID: 25353973
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programme.
Ferreira JP; Packer M; Sattar N; Butler J; Pocock SJ; Anker SD; Maldonado SG; Panova-Noeva M; Sumin M; Masson S; Zannad F; Januzzi JL
Eur J Heart Fail; 2024 Apr; 26(4):788-802. PubMed ID: 38439582
[TBL] [Abstract][Full Text] [Related]
12. Antigen carbohydrate 125 in heart failure: a promising clinical tool.
Núñez J; Miñana G; Núñez E; Sanchis J
Int J Cardiol; 2011 Aug; 150(3):369-70. PubMed ID: 21636139
[No Abstract] [Full Text] [Related]
13. Carbohydrate antigen 125: a new biomarker in heart failure.
Vizzardi E; D'Aloia A; Curnis A; Dei Cas L
Cardiol Rev; 2013; 21(1):23-6. PubMed ID: 22735832
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis.
D'Aloia A; Faggiano P; Aurigemma G; Bontempi L; Ruggeri G; Metra M; Nodari S; Dei Cas L
J Am Coll Cardiol; 2003 May; 41(10):1805-11. PubMed ID: 12767668
[TBL] [Abstract][Full Text] [Related]
15. Tumour marker levels in patients with chronic heart failure.
Varol E; Ozaydin M; Dogan A; Kosar F
Eur J Heart Fail; 2005 Aug; 7(5):840-3. PubMed ID: 15916923
[TBL] [Abstract][Full Text] [Related]
16. Tumour markers in chronic heart failure. Review of the literature and clinical implications.
Faggiano P; D'Aloia A; Antonini-Canterin F; Vizzardi E; Nicolosi GL; Cas LD
J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):573-9. PubMed ID: 16858234
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of carbohydrate antigen 125 in combination with N-terminal pro-brain natriuretic peptide in patients with acute decompensated heart failure.
Yoon JY; Yang DH; Cho HJ; Kim NK; Kim CY; Son J; Roh JH; Jang SY; Bae MH; Lee JH; Park HS; Cho Y; Chae SC
Korean J Intern Med; 2019 Jul; 34(4):811-818. PubMed ID: 30616330
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure.
Núñez J; Rabinovich GA; Sandino J; Mainar L; Palau P; Santas E; Villanueva MP; Núñez E; Bodí V; Chorro FJ; Miñana G; Sanchis J
PLoS One; 2015; 10(4):e0122360. PubMed ID: 25875367
[TBL] [Abstract][Full Text] [Related]
19. [Benefits of statin therapy based on plasma carbohydrate antigen 125 values following an admission for acute heart failure].
Núñez J; Sanchis J; Núñez E; Fonarow GC; Bodí V; Bertomeu-González V; Miñana G; Palau P; Fácila L; Chorro FJ; Bertomeu-Martínez V; Llàcer A
Rev Esp Cardiol; 2011 Dec; 64(12):1100-8. PubMed ID: 21958731
[TBL] [Abstract][Full Text] [Related]
20. Antigen carbohydrate 125 in heart failure: not just a surrogate for serosal effusions?
Núñez J; Miñana G; González M; Garcia-Ramón R; Sanchis J; Bodí V; Núñez E; Chorro FJ; Llàcer A; Miguel A
Int J Cardiol; 2011 Feb; 146(3):473-4. PubMed ID: 21193243
[No Abstract] [Full Text] [Related]
[Next] [New Search]
